Related Experiment Video
Updated: Apr 16, 2026
08:55
Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag
Published on: December 14, 2017
16.4K
The EIF4G1 gene and Parkinson's disease
H Deng1, Y Wu1,2, J Jankovic3
1Center for Experimental Medicine and Department of Neurology, the Third Xiangya Hospital, Central South University, Changsha, China.
Acta Neurologica Scandinavica
|March 14, 2015
Summary
Genetic variants in EIF4G1 are linked to Parkinson disease (PD). These EIF4G1 variants may impair cellular stress responses, contributing to neurodegeneration in Parkinson disease, though their frequency is low.
Area of Science:
- Neuroscience
- Genetics
- Molecular Biology
Background:
- Autosomal dominant Parkinson disease (PD) is associated with variants in the EIF4G1 gene (PARK18).
- The precise role of EIF4G1 variants in PD-related neurodegeneration remains unclear.
- Existing functional studies suggest potential mechanisms involving cellular stress response pathways.
Purpose of the Study:
- To investigate the role of EIF4G1 variants in the pathogenesis of Parkinson disease.
- To elucidate the functional consequences of EIF4G1 mutations in the context of neurodegeneration.
- To assess the contribution of EIF4G1 variants to PD development.
Main Methods:
- Review of identified EIF4G1 mutations/variants associated with PD.
- Analysis of functional studies examining cellular responses to stress in the presence of EIF4G1 variants.
- Exploration of the potential impact of EIF4G1 on cellular stress resilience.
Main Results:
- Several EIF4G1 mutations/variants have been found to be associated with Parkinson disease.
- Functional studies suggest these variants may compromise the dynamic cellular stress response.
- EIF4G1 variants are implicated in the development of PD, despite their low observed frequency.
Conclusions:
- EIF4G1 variants likely play a role in the pathogenicity of Parkinson disease.
- Impaired cellular stress response due to EIF4G1 variants may contribute to neurodegeneration.
- Further large-scale, diverse population studies on EIF4G1 expression and function are necessary.
Related Concept Videos
01:15Parkinson's Disease: Overview
2.5K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.5K
01:24Parkinson's Disease: Treatment
1.4K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.4K
01:37Neural Regulation
45.2K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
45.2K
01:21EPS and iPS Cells in Disease Research
3.5K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.5K
01:22Lysosomal Hydrolases
4.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.8K
01:58Cell Specific Gene Expression
17.4K
Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
17.4K